This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Hans E. Wagner, MD; Peter Thomas, PhD; Barbara C. Wolf, MD; Alan Rapoza; Glenn Steele, Jr, MD, PhD

Arch Surg. 1990;125(3):351-354.

Abstract
• It has been hypothesized that the metastatic capacity of tumors may be correlated with hypersialylation of the cell surface. We used a novel inhibitor of sialic acid incorporation, Kl-8110, to determine the effect of depletion of cell surface sialic acid on the metastatic behavior of three human colorectal cancer cell lines, in which hepatic seeding was related to tumor cell differentiation. Treatment of tumor cells with Kl-8110 prior to intrasplenic injection prevented liver colonization. Total cellular sialic acid was reduced, as was that of the cell surface. Secreted forms of carcinoembryonic antigen also were depleted of sialic acid by this treatment. These data show that depletion of sialic acid from cell surface glycoconjugates reduces the incidence of hepatic metastases from human colorectal primary tumors and adds to the mounting evidence of the importance of sialic acid in determining the biological behavior of tumor cells.

(Arch Surg. 1990;125:351-354)

Author Affiliations
From the Laboratory of Cancer Biology, Department of Surgery, New England Deaconess Hospital, Harvard Medical School, Boston, Mass.

Footnotes
Accepted for publication December 14, 1989.

Read before the annual meeting of the Society of Surgical Oncology, San Francisco, Calif, May 24, 1989.

Reprint requests to Laboratory of Cancer Biology, 50 Binney St, Boston, MA 02115 (Dr Wagner).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?